| abstract |
The present invention relates to a new class of JAK kinase inhibitor compounds, which are compounds of formula (I) and pharmaceutically acceptable salts, prodrugs, metabolites, isotope derivatives and solvates thereof, and compounds containing said compounds The pharmaceutical composition can be used for preventing or treating diseases and conditions associated with Janus kinase (JAK) in human patients and mammalian patients; and it can be used as a Janus kinase (JAK) inhibitor in medicine, pharmacy, biology, physiology, Applications in biochemistry and other experiments. (I). |